CEO

Where the World’s Most Powerful Meet the World’s Money: World Economic Forum & BlackRock

Covid-19, climate change, and China—the shared focus of the World Economic Forum's "Great Reset" and BlackRock's "economic restart."

FDA Grants Full Approval of Pfizer Vaccine, Critics Blast Agency for Lack of Data, Scientific Debate

Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.

FDA Approves Pfizer’s COVID Vax

U.S. drug regulators on Monday approved the COVID-19 vaccine from Pfizer and BioNTech for people 16 and older, making it the first such shot to receive approval in the country.

BlackRock Wants Investors to Increase China Exposure, Should You Follow?

BlackRock, the world’s largest investment manager with more than $9 trillion in assets under management, recently made a very contrarian call.

Massive Nurse Shortage Hits Houston—Weeks After 150 Unvaccinated Nurses and Hospital Workers Fired

Houston hospitals have “reached a breaking point” amid a COVID-19 outbreak, which struck weeks after 150 hospital workers were fired by Houston Methodist hospital, one of several hospitals struggling.

Conservative Media Company Is the Fastest-Growing Advertising And Marketing Business in the U.S., According to Inc. 5000

A conservative digital media company’s focus on the culture wars in America appears to be paying off, as it is the fastest-growing private advertising and marketing business in the U.S., according to the 2021 Inc. 5000 list released Tuesday.

High Inflation Could Be Stickier Than Anticipated

Companies raise prices in response to higher labor costs, fanning inflation further

Labor shortage has employers scrambling to offer new perks

Companies are rolling out perks at a feverish clip to lure employees.

The Epic v. Google lawsuit finally makes sense

Google pulled every trick it could, an unredacted complaint alleges

Advanced Weapons Developer D.A.R.P.A. Invested $25M in Moderna’s mRNA Vax in 2013

The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million "to research and develop its messenger RNA therapeutics" nearly 8 years ago.

Latest news

- Advertisement -spot_img